Aunt Ne

[Aunt Ne @aunt_ne]

@gtconway3d As funny as this is, in this bazaar time it wouldn’t surprise me lol

[Aunt Ne @aunt_ne]

We had such a good life. How does this happen to people? Why? Why? Why? Such a good man and the treatment available to him is shit! No one with the power to help cares. A true nightmare

[Aunt Ne @aunt_ne]

Forgive me for venting here. My family isn’t on X so I can be honest. I am having a meltdown because I am picking out a suit for my son’s wedding and it hit me that our son is getting married and his terminally ill father is his best man. It’s not supposed to be this way ….

[Aunt Ne @aunt_ne]

@ProjectLincoln Cuz MaMa thinks he is cute

[Aunt Ne @aunt_ne]

@JackPosobiec There was a saying in the plant where I worked that some guys were on the “carry out plan”. Mitch would qualify. Why anyone would want to spend the last part of life struggling at work is astounding.

[Aunt Ne @aunt_ne]

@P_Kallioniemi @MalcolmNance Nailed it 👏

[Aunt Ne @aunt_ne]

@AdamKinzinger Nothing but class!

[Aunt Ne @aunt_ne]

@elonmusk The government could provide free ID’s for all and end the argument.
They should also find a way to build up social security like they find ways to enrich themselves. Lots of magic millionaires in government.

[Aunt Ne @aunt_ne]

@bullishbruk I am always so happy to see the success stories for those fortunate enough to make the cut. ❤️It is also heart wrenching. My husband had an iffy mri Friday and is now scheduled for a pet scan. He was diagnosed in July of 26 and had had two craniotomies so far. 💔my soul hurts

[Aunt Ne @aunt_ne]

@Av8rLady @LoriMills4CA42 @megbasham Heartbreaking and beautiful

[Aunt Ne @aunt_ne]

@HollensbeAmanda That is the best news! Big hugs to both of you
I look forward to seeing your progress so much!

[Aunt Ne @aunt_ne]

@AdamKinzinger 😂 indeed

[Aunt Ne @aunt_ne]

#NewProfilePic

[Aunt Ne @aunt_ne]

@MeghanMcCain Calidum cibum - the play write reminded me of you

[Aunt Ne @aunt_ne]

@simonmaechling Amen!

[Aunt Ne @aunt_ne]

@krassenstein Cancer patients in dire need of drug approval by the fda being ignored while we watch those who have never had to suffer frolic about, living out their fantasies for all to see. It’s hard to watch. A gut punch

[Aunt Ne @aunt_ne]

@aroog1278 @NimraShahzadin You are so incredibly blessed

[Aunt Ne @aunt_ne]

@newstart_2024 When a catastrophic illness hits you get perspective real fast 😥

[Aunt Ne @aunt_ne]

@JoshReynolds24 @RepBrendanBoyle My God!

[Bullish @bullishbruk]

$IBRX
To FDA Oncology @FDAOncology officials: ANKTIVA an IL-15 receptor agonist that stimulates NK cells, T cells, and memory T cells, has demonstrated a strong safety profile across 10+ years of clinical data—including long-term follow-up exceeding 47 months in key studies—with mostly mild-to-moderate, localized side effects consistent with BCG instillation itself and very low rates of severe (Grade 3/4) adverse events (around 0-3%).
It has been under investigation and development for over a decade, showing durable responses and high response rates in cancer patients.
While treatments like chemo and radiation—with their low success rates and significant risks of severe harm—are widely available, why limit or delay broader access to this safer, immune-boosting option? What is one substantive, evidence-based reason to restrict or delay patient access beyond standard regulatory and trial design considerations—particularly given the unnecessary seven-month delay in reviewing the sBLA for papillary disease, despite NCCN guidelines and consensus among urologists that CIS and papillary NMIBC originate from the same cancer-inducing clone and should be treated similarly?
To the FDA’s internal gatekeepers and longstanding reviewers who influence these decisions: Patients and families facing all types of cancer deserve timely access to therapies backed by strong safety and efficacy data. Lives are on the line. We respectfully ask for a clear response focused on patient outcomes, or an acknowledgment that the evidence supports accelerated and broader use.
One has to wonder whether higher government officials are aware of these access challenges and could help expedite solutions. @BladderCancerUS @LoriMills4CA42 @FDA_KyleD